No abstract available
Keywords:
autism spectrum disorders; diagnostic; neurodegenerative disease; neurodevelopmental disease; saliva.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Saliva used as biological fluid to detect neurodegenerative and neurodevelopmental diseases
References
-
-
Ausó E., Gómez-Vicente V., Esquiva G. (2020). Biomarkers for Alzheimer's disease early diagnosis. J. Personal. Med. 10, 114. 10.3390/jpm10030114
-
DOI
-
PMC
-
PubMed
-
-
Bieleninik Ł., Gold C. (2021). Estimating components and costs of standard care for children with autism spectrum disorder in Europe from a large international sample. Brain Sci. 11, 1–9. 10.3390/brainsci11030340
-
DOI
-
PMC
-
PubMed
-
-
Bjerke M., Engelborghs S. (2018). Cerebrospinal fluid biomarkers for early and differential Alzheimer's disease diagnosis. J. Alzheimer's Dis. 62, 1199–1209. 10.3233/JAD-170680
-
DOI
-
PMC
-
PubMed
-
-
Goldoni R., Dolci C., Boccalari E., Inchingolo F., Paghi A., Strambini L., et al. . (2022). Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection. Ageing Res. Rev. 76:101587. 10.1016/j.arr.2022.101587
-
DOI
-
PubMed
-
-
Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Banerjee S., et al. . (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 396, 413–446. 10.1016/S0140-6736(20)30367-6
-
DOI
-
PMC
-
PubMed